Torrent Pharmaceuticals to announce Q3 results and consider interim dividend

On 03 February 2017

Torrent Pharmaceuticals announced that a meeting of the Board of Directors of the Company will be held on 03 February 2017, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31 December 2016 (Q3).

Futher, in the above meeting the Board would also consider payment of Interim Dividend for the year 2016-17.

Powered by Capital Market - Live News